Back to Search
Start Over
Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.
- Source :
-
Liver International . Aug2022, Vol. 42 Issue 8, p1981-1990. 10p. 2 Charts, 1 Graph. - Publication Year :
- 2022
-
Abstract
- Hepatitis B virus (HBV) infection and nonalcoholic fatty liver disease (NAFLD) are two major causes of chronic liver disease (CLD) that can cause liver cirrhosis and hepatocellular carcinoma (HCC). It is a trend to superimpose NAFLD on chronic HBV infection in Asia. This review presents the epidemiology of concurrent NAFLD in chronic hepatitis B (CHB) patients and focuses on the impact of concurrent NAFLD on the outcome of CHB patients in Asia. Although CHB patients tend to have a lower prevalence and incidence of NAFLD than the general population, concurrent NAFLD among CHB patients is still common and has an upward trend over time. Concurrent NAFLD can promote hepatitis B surface antigen (HBsAg) seroclearance and might inhibit HBV replication but exacerbate liver fibrosis. The impacts of concurrent NAFLD on HCC risk, allācause mortality and antiviral treatment response in CHB patients remain controversial. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 14783223
- Volume :
- 42
- Issue :
- 8
- Database :
- Academic Search Index
- Journal :
- Liver International
- Publication Type :
- Academic Journal
- Accession number :
- 158144297
- Full Text :
- https://doi.org/10.1111/liv.15252